Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
European Heart Journal|September 4, 2013
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial, Linda G Mellbin, Lars Rydén, et al.
Diabetes Care|April 28, 2005
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylureaDavid M Kendall, Matthew C Riddle, Julio Rosenstock, et al.
Diabetes Care|September 15, 2018
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover StudyMatthew C Riddle, Rajaa Nahra, Jenny Han, et al.
Diabetes Care|May 1, 2013
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)Matthew C Riddle, Ronnie Aronson, Philip Home, et al.
Diabetes Care|March 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 DiabetesGeremia B Bolli, Philip D Home, Francesca Porcellati, et al.
Postgraduate Medicine|June 12, 2014
A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitusIrl B Hirsch, Doron Schneider, Aaron King, et al.
Diabetes/Metabolism Research and Reviews|April 25, 2006
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metforminMatthew C Riddle, Robert R Henry, Terri H Poon, et al.
Diabetes Care|August 23, 2014
Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forumWilliam T Cefalu, John B Buse, Stefano Del Prato, et al.
Cardiovascular Diabetology|September 26, 2021
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWINDManige Konig, Matthew C Riddle, Helen M Colhoun, et al.
Diabetes Care|November 1, 2019
<i>Diabetes Care</i> Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and CareMatthew C Riddle, Lawrence Blonde, Hertzel C Gerstein, et al.
Pageof 9